Expanded CDMO Capabilities
On the Journey to Support Drug Developers With End-to-End Outsourcing
Michelle Hall
Mikart
PAO-06-23-CL-04Jul 17, 2023
Microbiome Therapeutic Innovation
Unleashing the Power of the Microbiome: Advancements, Challenges, and the Therapeutic Future
Stacy Burns-Guydish, Ph.D.; Gary Henderson
List Labs
PAO-03-23-CL-08Apr 04, 2023
Microbiome-Based CDMO
Expanding a Leadership Position in Microbiome-Based Contract Development and Manufacturing
Stacy Burns-Guydish, Ph.D.; Jonathan Yongwan Jo; Gary Henderson; Michael Kimble
List Labs
PAO-11-022-CL-13Dec 13, 2022
New Facility
AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus
AGC Biologics
PR-M05-22-13-359May 18, 2022
mRNA
Leveraging Existing Technologies with New Dedicated Facilities for mRNA Projects
Scott Doncaster; Marc Sauer, Ph.D.
BIOVECTRA
PAO-02-022-CL-07Mar 12, 2022
New Capabilities
Discovery Life Sciences Streamlines Cell and Gene Therapy Manufacturing with Expanded Human Cellular Starting Materials
Discovery Life Sciences
PR-M02-22-15Feb 17, 2022